Región Metropolitana de Santiago
Este organismo compró $13.490.071.704.271 en 34.367 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $954,5 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2268-42-AG26 | 09-03-2026 | Tecnologia Bs SpA | Aceptada | $4.980.150 |
| 2268-41-AG26 | 08-03-2026 | Remodelate SpA | Aceptada | $6.650.000 |
| 2268-40-AG26 | 06-03-2026 | Novofarma Service S.A. | Aceptada | $1.413.720 |
| 621-1340-TD25 | 06-03-2026 | Centro Especialidades Farmaceuticas Limitada | Aceptada | $1.913.139.505 |
| 621-250-TD26 | 05-03-2026 | Novofarma Service S.A. | Aceptada | $81.366.250 |
| 2268-276-AG25 | 04-03-2026 | Importadora y Comercializadora Ugarit Limitada | Aceptada | $1.547.000 |
| 621-92-SE26 | 03-03-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $1.482.316.703 |
| 621-109-SE26 | 03-03-2026 | Helios Med Solutions SpA | Aceptada | $26.372.304 |
| 621-214-SE26 | 03-03-2026 | Alembic Pharmaceuticals SpA | Aceptada | $259.861.728 |
| 621-217-SE26 | 03-03-2026 | Pfizer Chile S.A. | Aceptada | $171.360.000 |
| 621-232-SE26 | 03-03-2026 | Gador Limitada | Aceptada | $96.197.220 |
| 621-180-SE26 | 03-03-2026 | Centro Especialidades Farmaceuticas Limitada | Aceptada | $9.943.121 |
| 621-178-SE26 | 03-03-2026 | Parthenon Pharma SpA | Aceptada | $7.604.100 |
| 621-173-SE26 | 02-03-2026 | Blau Farmaceutica Chile SpA | Aceptada | $511.628.124 |
| 621-1379-SE25 | 02-03-2026 | Articulos Medicos y Quirurgicos Chile S.A. | Aceptada | $15.783.446 |
| 621-144-SE26 | 02-03-2026 | Trade Foods & Nutrients SpA | Aceptada | $408.051.000 |
| 621-153-SE26 | 02-03-2026 | Dfm Pharma SpA | Aceptada | $2.980.688.795 |
| 621-162-SE26 | 02-03-2026 | Cristalia Chile SpA | Aceptada | $1.301.321.549 |
| 621-164-SE26 | 02-03-2026 | Laboratorios Andromaco S.A. | Aceptada | $10.291.912.788 |
| 621-207-SE26 | 02-03-2026 | Endotec S.A. | Aceptada | $98.863.772 |
| 621-208-SE26 | 02-03-2026 | Emcure Pharma Chile SpA | Aceptada | $163.085.990 |
| 621-209-SE26 | 02-03-2026 | Alembic Pharmaceuticals SpA | Aceptada | $368.372.592 |
| 621-213-SE26 | 02-03-2026 | Emcure Pharma Chile SpA | Aceptada | $91.046.995 |
| 621-216-SE26 | 02-03-2026 | Emcure Pharma Chile SpA | Aceptada | $141.811.634 |
| 621-221-SE26 | 02-03-2026 | Ascend Laboratories SpA | Aceptada | $137.827.722 |
| 621-191-SE26 | 02-03-2026 | Bestpharma S.A. | Aceptada | $887.546.268 |
| 621-240-SE26 | 27-02-2026 | Astrazeneca S.A. | Aceptada | $77.808.243 |
| 621-241-SE26 | 27-02-2026 | Novofarma Service S.A. | Aceptada | $220.472.847 |
| 621-39-TD26 | 27-02-2026 | Aventis Pharma Holding Gmbh | Aceptada | $32.369.547 |
| 621-58-SE26 | 27-02-2026 | Vitafarma S.A. | Aceptada | $453.880.875 |
